婴幼儿喉部血管瘤治疗进展  

Advances in the treatment of infantile hemangiomas of the larynx

作　　者：高星 占小俊 谷庆隆[1] GAO Xing;ZHAN Xiaojun;GU Qinglong(Department of Otolaryngology Head and Neck Surgery,Children's Hospital,Capital Institute of Pediatrics,Beijing,100020,China)

机构地区：[1]首都儿科研究所附属儿童医院耳鼻咽喉头颈外科,北京100020

出　　处：《临床耳鼻咽喉头颈外科杂志》2023年第12期972-976,共5页Journal of Clinical Otorhinolaryngology Head And Neck Surgery

基　　金：首都卫生发展科研专项(No:首发2022-1-2101)。

摘　　要：婴幼儿血管瘤是婴幼儿较为常见的软组织肿瘤,在足月新生儿中的患病率约为4.5%。声门下血管瘤是一种比较罕见的血管瘤,其位置特殊常引起患儿呼吸窘迫,具有潜在的生命危险,因此需要临床医师结合患儿临床表现、辅助检查、患儿病史及生命体征评估做出准确诊断并制定详细的治疗方案。本文以婴幼儿血管瘤为综述对象,描述其病理生理机制,对目前常用的治疗方法进行较为详细的论述。Infantile hemangiomas are relatively common soft tissue tumors in infants and young children,with aprevalence of about 4.5%in full-term newborns.Subglottic Hemangioma(SGH)is a relatively rare type of hemangioma,and its special location often causes respiratory distress and potentially life-threatening conditions in infants.Therefore,it is necessary for clinicians to make an accurate diagnosis and formulate a detailed treatment plan based on the clinical manifestations,the auxiliary examinations,the medical history and A the vital signs evaluation of patients.This review describes the pathophysiological mechanism of infantile hemangioma and provides a detailed discussion on commonly used treatment methods in detail.

关 键 词：婴幼儿血管瘤 声门下血管瘤 Β受体阻滞剂 硬化剂注射治疗 

分 类 号：R767[医药卫生—耳鼻咽喉科]